• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗多囊卵巢综合征患病率研究中的脂积累产物与胰岛素抵抗。

Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study.

机构信息

Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran.

出版信息

Clin Endocrinol (Oxf). 2014 Jul;81(1):52-7. doi: 10.1111/cen.12287. Epub 2013 Aug 9.

DOI:10.1111/cen.12287
PMID:23844634
Abstract

OBJECTIVE

To evaluate diagnostic accuracy of lipid accumulation product (LAP) index as a marker of insulin resistance in a community-based population with polycystic ovary syndrome (PCOS), compared with healthy women.

METHODS

Anthropometric measurements, biochemical parameters, LAP index and insulin resistance (IR) were compared in 134 PCOS subjects and 414 healthy women recruited from 1126 reproductive aged women (18-45 years), participants of the Iranian PCOS Prevalence Study. LAP was defined as [WC (cm)-58] ×TG (mmol/l)]. PCOS was diagnosed using the Rotterdam criteria, and IR was defined using the homeostatic model assessment IR. LAP, body mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR) were compared using the two-tailed Spearman rank correlation test and analysing the receiver operating characteristic (ROC) curves for IR.

RESULTS

Among the PCOS subjects, the mean ± SD age, BMI, WC and WHR were 32·2 ± 7·7 years, 26·8 ± 5·8 kg/m(2) , 85·2 ± 13·2 cm and 0·80 ± 0·06, respectively, and the median (IQ25-75) of LAP index was 34·03 (17·8-66·3). There was significant correlation between HOMA-IR index and LAP in patients with PCOS (r = 0·41; P < 0·001). Also, ROC curves analysis revealed that the optimal cut-off value for LAP to define the presence of IR was 34·1 (sensitivity: 75%; specificity: 58%). LAP showed the highest area under curve (AUC) (P < 0·001).

CONCLUSION

Among PCOS subjects, LAP index has the strongest diagnostic accuracy for detection of IR in comparison with BMI, WC and WHR.

摘要

目的

评估脂联素聚集产物(LAP)指数作为多囊卵巢综合征(PCOS)患者胰岛素抵抗标志物的诊断准确性,与健康女性进行比较。

方法

在伊朗 PCOS 患病率研究的 1126 名育龄女性(18-45 岁)参与者中,招募了 134 名 PCOS 患者和 414 名健康女性,比较了这些女性的人体测量学指标、生化参数、LAP 指数和胰岛素抵抗(IR)。LAP 定义为[WC(cm)-58]×TG(mmol/l)]。采用 Rotterdam 标准诊断 PCOS,采用稳态模型评估 IR 定义 IR。使用双尾 Spearman 秩相关检验比较 LAP、体重指数(BMI)、腰围(WC)和腰臀比(WHR),并分析用于 IR 的受试者工作特征(ROC)曲线。

结果

在 PCOS 患者中,平均±标准差年龄、BMI、WC 和 WHR 分别为 32.2±7.7 岁、26.8±5.8kg/m²、85.2±13.2cm 和 0.80±0.06,LAP 指数的中位数(25-75%分位数)为 34.03(17.8-66.3)。在 PCOS 患者中,HOMA-IR 指数与 LAP 呈显著相关性(r=0.41;P<0.001)。此外,ROC 曲线分析显示,LAP 定义 IR 存在的最佳截断值为 34.1(敏感性:75%;特异性:58%)。LAP 具有最高的曲线下面积(AUC)(P<0.001)。

结论

在 PCOS 患者中,与 BMI、WC 和 WHR 相比,LAP 指数对 IR 的诊断准确性最高。

相似文献

1
Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study.伊朗多囊卵巢综合征患病率研究中的脂积累产物与胰岛素抵抗。
Clin Endocrinol (Oxf). 2014 Jul;81(1):52-7. doi: 10.1111/cen.12287. Epub 2013 Aug 9.
2
Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.多囊卵巢综合征患者与正常排卵非多毛妇女各种肥胖指数的比较:基于人群的研究。
Eur J Endocrinol. 2014 Aug;171(2):199-207. doi: 10.1530/EJE-14-0094. Epub 2014 May 9.
3
The lipid accumulation product is associated with impaired glucose tolerance in PCOS women.脂滴产物与 PCOS 女性的葡萄糖耐量受损有关。
J Clin Endocrinol Metab. 2011 Jun;96(6):E986-90. doi: 10.1210/jc.2011-0031. Epub 2011 Apr 6.
4
The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.脂质蓄积产物(LAP)和内脏脂肪指数(VAI)对患有多囊卵巢综合征的瘦女性临床、激素及代谢参数的影响。
Gynecol Endocrinol. 2019 Mar;35(3):233-236. doi: 10.1080/09513590.2018.1519794. Epub 2018 Oct 10.
5
Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome.脂质积聚产物指数:多囊卵巢综合征心血管风险的可靠标志物。
Hum Reprod. 2009 Jul;24(7):1726-31. doi: 10.1093/humrep/dep072. Epub 2009 Mar 27.
6
Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.中国西南地区肥胖/非肥胖多囊卵巢综合征女性体脂指数作为胰岛素抵抗的有效预测指标。
Endocrine. 2019 Jul;65(1):81-85. doi: 10.1007/s12020-019-01912-1. Epub 2019 Mar 28.
7
The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study.多囊卵巢综合征与代谢综合征之间缺乏关联:伊朗多囊卵巢综合征患病率研究。
Clin Endocrinol (Oxf). 2011 Nov;75(5):692-7. doi: 10.1111/j.1365-2265.2011.04113.x.
8
Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.脂质蓄积产物(LAP)和内脏脂肪指数(VAI)作为阿根廷多囊卵巢综合征年轻女性胰岛素抵抗和代谢相关紊乱标志物的研究
Horm Metab Res. 2017 Jan;49(1):23-29. doi: 10.1055/s-0042-113463. Epub 2016 Aug 29.
9
The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.内脏脂肪指数(VAI)和脂类蓄积产物(LAP)是肥胖/超重多囊卵巢综合征妇女胰岛素抵抗和高雄激素血症的预测因子。
Biomed Res Int. 2023 Feb 13;2023:1508675. doi: 10.1155/2023/1508675. eCollection 2023.
10
Characteristics of Different Obesity Metabolic Indexes and their Correlation with Insulin Resistance in Patients with Polycystic Ovary Syndrome.不同肥胖代谢指标特征及其与多囊卵巢综合征患者胰岛素抵抗的相关性。
Reprod Sci. 2024 Sep;31(9):2829-2835. doi: 10.1007/s43032-024-01532-9. Epub 2024 Apr 22.

引用本文的文献

1
Association of visceral adiposity index and lipid accumulation products with prediabetes in US adults from NHANES 2007-2020: A cross-sectional study.美国成年人中内脏脂肪指数和脂质蓄积产物与糖尿病前期的关系:一项横断面研究。
PLoS One. 2024 Sep 30;19(9):e0311312. doi: 10.1371/journal.pone.0311312. eCollection 2024.
2
Body adiposity markers and insulin resistance in patients with type 1 diabetes.1 型糖尿病患者的体脂肪标志物与胰岛素抵抗。
Arch Endocrinol Metab. 2023 Mar 30;67(3):401-407. doi: 10.20945/2359-3997000000599. Epub 2023 Feb 7.
3
Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.
脂质比率和肥胖指数是多囊卵巢综合征女性代谢综合征的有效预测指标。
Ther Adv Endocrinol Metab. 2022 Jan 10;13:20420188211066699. doi: 10.1177/20420188211066699. eCollection 2022.
4
Body Fat Indices as Effective Predictors of Insulin Resistance in Obstructive Sleep Apnea: Evidence from a Cross-Sectional and Longitudinal Study : BFI as Predictors of IR in OSA.体脂指数可有效预测阻塞性睡眠呼吸暂停中的胰岛素抵抗:来自横断面和纵向研究的证据
Obes Surg. 2021 May;31(5):2219-2230. doi: 10.1007/s11695-021-05261-9. Epub 2021 Feb 10.
5
Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome.在多囊卵巢综合征女性中,脂质积聚产物与通过受控衰减参数量化的肝脂肪变性独立相关。
Endocr Connect. 2020 Feb;9(2):154-162. doi: 10.1530/EC-19-0559.
6
Assessment of adiposity distribution and its association with diabetes and insulin resistance: a population-based study.肥胖分布及其与糖尿病和胰岛素抵抗的关联评估:一项基于人群的研究。
Diabetol Metab Syndr. 2019 Jun 27;11:51. doi: 10.1186/s13098-019-0450-x. eCollection 2019.
7
Overtime trend of thyroid hormones and thyroid autoimmunity and ovarian reserve: a longitudinal population study with a 12-year follow up.甲状腺激素和甲状腺自身免疫与卵巢储备功能的超时趋势:一项 12 年随访的纵向人群研究。
BMC Endocr Disord. 2019 May 7;19(1):47. doi: 10.1186/s12902-019-0370-7.
8
Optimal Cutoff Points for Anthropometric Variables to Predict Insulin Resistance in Polycystic Ovary Syndrome.预测多囊卵巢综合征胰岛素抵抗的人体测量学变量的最佳切点
Int J Endocrinol Metab. 2017 Jul 30;15(4):e12353. doi: 10.5812/ijem.12353. eCollection 2017 Oct.
9
Effect of Metformin-sustained Release Therapy on Low-density Lipoprotein Size and Adiponectin in the South Indian Women with Polycystic Ovary Syndrome.二甲双胍缓释疗法对南印度多囊卵巢综合征女性低密度脂蛋白大小和脂联素的影响。
Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):679-683. doi: 10.4103/ijem.IJEM_154_17.
10
Role of Versican and ADAMTS-1 in Polycystic Ovary Syndrome.多功能蛋白聚糖和含血小板反应蛋白基序的解聚蛋白-1在多囊卵巢综合征中的作用。
J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):24-30. doi: 10.4274/jcrpe.3414. Epub 2016 Dec 2.